Intellia Therapeutics
0 sources
Financials
0001193125-26-076550Intellia Therapeutics
Summary
Intellia Therapeutics is a company[1]. It ranks in the top 8% of company entities by monthly Wikipedia readership (184 views/month).[2]
Key Facts
- Intellia Therapeutics is credited with the discovery of Jennifer Doudna[3].
- Intellia Therapeutics is in the country of United States[4].
- Intellia Therapeutics is in the country of US[5].
- Intellia Therapeutics's instance of is recorded as company[6].
- Intellia Therapeutics's instance of is recorded as public company[7].
- Intellia Therapeutics's headquarters location is recorded as Cambridge[8].
- Intellia Therapeutics's stock exchange is recorded as Nasdaq[9].
- Intellia Therapeutics's industry is recorded as Biotherapeutics[10].
- Intellia Therapeutics's industry is recorded as biotechnology[11].
- January 1, 2014 marks the founding of Intellia Therapeutics[12].
- 2014-05-07 marks the founding of Intellia Therapeutics[13].
- Intellia Therapeutics's official website is recorded as http://intelliatx.com/[14].
- Intellia Therapeutics's legal form is recorded as public limited company[15].
- Intellia Therapeutics's legal form is recorded as XTIQ[16].
- Intellia Therapeutics's social media followers is recorded as {'amount': '+5603'}[17].
- Intellia Therapeutics's social media followers is recorded as {'amount': '+4181'}[18].
- Intellia Therapeutics's social media followers is recorded as {'amount': '+10282'}[19].
Product Details
The following facts are restated verbatim from public-domain and CC0 open-data sources — every line is independently verifiable against the named source's catalog.
GLEIF Golden Copy — Level 1 entity data
-
Legal Entity Identifier (LEI): 5493002T5BCPE5DZC723[20]
-
Registered legal name: Intellia Therapeutics, INC.[21]
-
Legal jurisdiction: US-DE[22]
-
GLEIF entity category: GENERAL[23]
-
Legal form (ISO 20275 ELF): XTIQ[24]
-
Entity status: ACTIVE[25]
-
LEI registration status: ISSUED[26]
-
Entity created: 2014-05-07[27]
-
LEI first registered: 2016-03-11[28]
-
LEI last updated: 2025-09-02[29]
-
LEI next renewal: 2026-09-02[30]
-
Managing LOU: 5299000J2N45DDNE4Y28[31]
-
Registration authority: RA000602[32]
-
Authority entity ID: 5529972[33]
-
Conformity flag: NON_CONFORMING[34]
Body
Founding
Recorded inception include January 1, 2014[12] and 2014-05-07[13].
Operations
Intellia Therapeutics's headquarters location is recorded as Cambridge[8].
Industry
Industries include Biotherapeutics[10] and biotechnology[11].
Ownership
Intellia Therapeutics's stock exchange is recorded as Nasdaq[9].
Why It Matters
Intellia Therapeutics ranks in the top 8% of company entities by monthly Wikipedia readership (184 views/month).[2]